ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Reagan/Congress Budget Compromise Seems Likely, Would Loosen FY 1982 Spending Limits On NCI

December 11, 1981

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

NIH RPG Success Rate to Fall Further

June 7, 2013

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012